GlassScriptPhysician profile
Roger D Sung
NPI 1215982764
$111,865.88
in general payments reported to CMS, 2019-2025
17 companies · $823 in 2025
The $823 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101K · 2020: $368 · 2021: $661 · 2022: $4,453 · 2023: $3,828 · 2024: $375 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,377 · Food and Beverage: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,377.01 |
| Food and Beverage | $1,649.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinefrontier, INC. | $99,327.29 | 2019-2025 | Sijfuse, Nanofuse, Facetfuse |
| Innovasis INC | $7,472.21 | 2019-2023 | |
| Nevro Corp. | $1,716.45 | 2019-2024 | Senza |
| Boston Scientific Corporation | $1,030.42 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Nuvasive, INC. | $641.08 | 2022 | |
| Stability Biologics, LLC | $374.53 | 2019-2024 | |
| Orthofix Medical, INC. | $263.38 | 2021-2025 | Spinal-Stim |
| Providence Medical Technology, INC. | $157.36 | 2019-2021 | |
| Medtronic, INC. | $152.34 | 2022-2025 | Inceptiv, Accurian, Intellis Adaptivestim |
| Centinel Spine, LLC | $134.56 | 2021 | |
| Globus Medical, INC. | $133.15 | 2025 | Senza |
| Spinal Elements, INC. | $130.98 | 2025 | |
| Axiomed LLC | $102.10 | 2022 | |
| Abbott Laboratories | $91.81 | 2019-2024 | Eterna |
| Si-Bone, INC. | $87.89 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $32.08 | 2023 | Stimulan |
| Osseus Fusion Systems, LLC | $18.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$6,200,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Sung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.